ArticleCancers2023

Longitudinal Plasma Proteomics-Derived Biomarkers Predict Response to MET Inhibitors for MET-Dysregulated NSCLC.

Guang-Ling Jie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.